Skip to main content
SpringerLink
Log in

Idiopathische Lungenfibrose (IPF)

Anti-Reflux-OP bei IPF könnte Verlauf bessern

  • journal club
  • Published:
Pneumo News Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

1

Literatur

  1. Raghu G, Collard HR, Egan JJ et al. Am J Respir Crit Care Med. 2011;183:788–824

    Article  Google Scholar 

  2. Raghu G, Meyer KC. Eur Respir J. 2012;39:242–45

    Article  CAS  Google Scholar 

  3. Raghu G, Freudenberger TD, Yang S et al. Eur Respir J. 2006;27:136–42

    Article  CAS  Google Scholar 

  4. Sweet MP, Patti MG, Leard LE et al. J Thorac Cardiovasc Surg. 2007;133:1078–84

    Article  Google Scholar 

  5. Tobin RW, Pope CE 2nd, Pellegrini CA et al. Am J Respir Crit Care Med. 1998;158:1804–08

    Article  CAS  Google Scholar 

  6. Johannson KA, Strambu I, Ravaglia C et al. Lancet Respir Med. 2017;5:591–98

    Article  Google Scholar 

  7. Ghebre YT, Raghu G. Am J Respir Crit Care Med. 2016;193:1345–52

    Article  CAS  Google Scholar 

  8. Raghu G, Yang ST, Spada C et al.. Chest. 2006;129:794–800

    Article  Google Scholar 

  9. Lee JS, Collard HR, Anstrom KJ et al. Lancet Respir Med. 2013;1:369–76

    Article  Google Scholar 

  10. Kreuter M, Spagnolo P, Wuyts W et al. Antacid therapy and disease progression in patients with idiopathic pulmonary fibrosis who received pirfenidone. Respiration. 2017;93:415–23

    Article  CAS  Google Scholar 

  11. Raghu G, Morrow E, Collins BF et al. Eur Respir J. 2016;48:826–32

    Article  Google Scholar 

  12. Lee JS, Song JW, Wolters PJ et al. Eur Respir J. 2012;39:352–58

    Article  CAS  Google Scholar 

Originalie

  • Raghu G, Pellegrini CA, Yow E et al. Laparoscopic anti-reflux surgery for the treatment of idiopathic pulmonary fibrosis (WRAP-IPF): a multicentre, randomised, controlled phase 2 trial. Lancet Respir Med. 2018 Sep;6(9):707–14.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medizinische Klinik V, Pneumologie Herz-Thorax-Zentrum Fulda, Klinikum Fulda gAG, Pacelliallee 4, 36043, Fulda, Deutschland

    Philipp Markart (Direktor, Stellvertretender Leiter Schwerpunkt: „Fibrosierende Lungenerkrankungen“)

  2. Universitätsklinikum Giessen Marburg GmbH, Klinikstrasse 36, 35392, Giessen, Deutschland

    Philipp Markart (Direktor, Stellvertretender Leiter Schwerpunkt: „Fibrosierende Lungenerkrankungen“) &  Andreas Günther (Chefarzt, Leiter Schwerpunkt: „Fibrosierende Lungenerkrankungen“)

  3. AGAPLESION Pneumologische Klinik, Waldhof-Elgershausen, 35753, Greifenstein, Deutschland

    Andreas Günther (Chefarzt, Leiter Schwerpunkt: „Fibrosierende Lungenerkrankungen“)

Authors
  1. Philipp Markart
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Andreas Günther
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Philipp Markart.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Markart, P., Günther, A. Anti-Reflux-OP bei IPF könnte Verlauf bessern. Pneumo News 10, 18–20 (2018). https://doi.org/10.1007/s15033-018-1017-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15033-018-1017-5

Search

Navigation